The Center for Biosignal Research (CBR) focuses on the study and clinical use of biosignals, or signals that can be continuously measured and monitored from the human body. CBR brings together engineers, scientists, and clinicians across a range of disciplines to advance biosignal research, with emphasis on real-world clinical implementation and improving patient care. Our areas of research broadly focus on improving biosignal analysis through signal processing and advanced algorithms, identifying predictors of adverse outcomes, using biosignals to improve physiologic understanding and leveraging these insights to improve patient care and reduce false alarms in bedside monitoring.
The CBR is based in the UCSF Division of Cardiology and the Cardiovascular Research Institute, and is part of the Berkeley/UCSF Computational Precision Health Program.
Mission:
Use biosignals to improve biological understanding and patient care
Vision:
Deepen biologic understanding and discovery for cardiovascular disease
Develop new methodologies for biosignal analysis, including new biosignal-based algorithms/technologies
Improve existing biosignal metrics and measurements
Improve patient care through clinical implementation and deployment
Support investigators to conduct biosignal research
Train and educate the next generation of cross-disciplinary experts
Maintain a repository of a broad array of biosignals for research and validation
